Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: Results in racial/ethnic subgroups

Journal of the American Society of Hypertension

Volumn 5, Issue 4, 2011, Pages 249-258

  Ofili, Elizabeth O ^a   Oparil, Suzanne ^b   Giles, Thomas ^c   Pitt, Bertram ^d   Purkayastha, Das ^e   Hilkert, Robert ^e   Samuel, Rita ^e   Sowers, James R ^f  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

^f University of Missouri   (United States)

Author keywords

combination therapy; Racial differences

Indexed keywords

AMLODIPINE PLUS VALSARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; HYDROCHLOROTHIAZIDE; OLMESARTAN;

ADD ON THERAPY; ADULT; AFRICAN AMERICAN; AGED; ANTIHYPERTENSIVE THERAPY; CAUCASIAN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG RESPONSE; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HISPANIC; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; MALE; MEAN SITTING DIASTOLIC BLOOD PRESSURE; MEAN SITTING SYSTOLIC BLOOD PRESSURE; MONOTHERAPY; PARALLEL DESIGN; PERIPHERAL EDEMA; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHINOPHARYNGITIS; SIDE EFFECT; SITTING; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION;

EID: 79960558916     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2011.02.007     Document Type: Article

References (22)

1. C.D. Fryar, R. Hirsch, M.S. Eberhardt, S.S. Yoon, and J.D. Wright Hypertension, high serum total cholesterol, and diabetes: racial and ethnic prevalence differences in U.S. adults, 1999-2006 NCHS Data Brief 36 2010 1 8
2. D. Lloyd-Jones, R.J. Adams, T.M. Brown, M. Carnethon, S. Dai, and G. de Simone Heart disease and stroke statistics - 2010 update: a report from the American Heart Association Circulation 121 2010 e46 e215
3. J.A. Cutler, P.D. Sorlie, M. Wolz, T. Thom, L.E. Fields, and E.J. Roccella Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004 Hypertension 52 2008 818 827
4. J.G. Douglas, G.L. Bakris, M. Epstein, K.C. Ferdinand, C. Ferrario, and J.M. Flack Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks Arch Intern Med 163 2003 525 541 (Pubitemid 36314340)
5. K.C. Ferdinand, and D.P. Ferdinand Race-based therapy for hypertension: possible benefits and potential pitfalls Expert Rev Cardiovasc Ther 6 2008 1357 1366
6. M. Rahman, J.G. Douglas, and J.T. Wright Jr. Pathophysiology and treatment implications of hypertension in the African-American population Endocrinol Metab Clin North Am 26 1997 125 144 (Pubitemid 27123898)
7. R.E. Schmieder, and L.M. Ruilope Blood pressure control in patients with comorbidities J Clin Hypertens (Greenwich) 10 2008 624 631
8. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252 (Pubitemid 37553153)
9. G. Mancia, S. Laurent, E. Agabiti-Rosei, E. Ambrosioni, M. Burnier, and M.J. Caulfield Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document J Hypertens 27 2009 2121 2158
10. J.M. Flack, D.A. Sica, G. Bakris, A.L. Brown, K.C. Ferdinand, and R.H. Grimm Jr. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement Hypertension 56 2010 780 800
11. J.M. Flack, D.A. Calhoun, L. Satlin, M. Barbier, R. Hilkert, and P. Brunel Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study J Hum Hypertens 23 2009 479 489
12. S. Oparil, T. Giles, E.O. Ofili, B. Pitt, Y. Seifu, and R. Samuel Moderate vs intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy J Hypertens 29 2011 161 170
13. B. Williams, N.R. Poulter, M.J. Brown, M. Davis, G.T. McInnes, and J.F. Potter Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV J Hum Hypertens 18 2004 139 185 (Pubitemid 38425770)
14. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
15. T.R. Smith, T. Philipp, B. Vaisse, G.L. Bakris, M. Wernsing, and J. Yen Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies J Clin Hypertens (Greenwich) 9 2007 355 364
16. M. Destro, A. Luckow, M. Samson, A. Kandra, and P. Brunel Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study J Am Soc Hypertens 2 2008 294 302
17. D.A. Calhoun, Y. Lacourcire, Y.T. Chiang, and R.D. Glazer Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial Hypertension 54 2009 32 39
18. Calhoun D, Glazer R, Yen J, Lacourciere Y. Effect of age, gender, race and ethnicity on efficacy of amlodipine/valsartan/hydrochlorothiazide triple combination therapy in patients with moderate to severe hypertension. Presented at: 24th Annual Scientific Meeting and Exposition of the American Society of Hypertension; May 6-9, 2009; San Francisco, CA. Poster P-266.
19. L.J. Appel, J.T. Wright Jr., T. Greene, L.Y. Agodoa, B.C. Astor, and G.L. Bakris Intensive blood-pressure control in hypertensive chronic kidney disease N Engl J Med 363 2010 918 929
20. S.G. Chrysant, M. Melino, S. Karki, J. Lee, and R. Heyrman The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study Clin Ther 30 2008 587 604 (Pubitemid 351680489)
21. S.G. Chrysant, J. Lee, M. Melino, S. Karki, and R. Heyrman Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension J Hum Hypertens 24 2010 730 738
22. S. Oparil, S.G. Chrysant, M. Melino, J. Lee, S. Karki, and R. Heyrman Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial J Hum Hypertens 24 2010 831 838